New tuberculosis drug enters human trials.

Research output: Contribution to journal › Article › peer-review

2 Citations (Scopus)

Original language	English (UK)
Pages (from-to)	475
Number of pages	1
Journal	The Lancet Infectious Diseases
Volume	5
Issue number	8
DOIs	https://doi.org/10.1016/S1473-3099(05)70181-X
Publication status	Published - Aug 2005
Externally published	Yes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

@article{eec04569a23e4a7f8e5e4cbb6ddc95cf,

title = "New tuberculosis drug enters human trials.",

author = "Khabir Ahmad",

year = "2005",

month = aug,

doi = "10.1016/S1473-3099(05)70181-X",

language = "English (UK)",

volume = "5",

pages = "475",

journal = "The Lancet Infectious Diseases",

issn = "1473-3099",

publisher = "Elsevier Ltd.",

number = "8",

}

TY - JOUR

T1 - New tuberculosis drug enters human trials.

AU - Ahmad, Khabir

PY - 2005/8

Y1 - 2005/8

UR - https://www.scopus.com/pages/publications/23844529239

U2 - 10.1016/S1473-3099(05)70181-X

DO - 10.1016/S1473-3099(05)70181-X

M3 - Article

C2 - 16094736

AN - SCOPUS:23844529239

SN - 1473-3099

VL - 5

SP - 475

JO - The Lancet Infectious Diseases

JF - The Lancet Infectious Diseases

IS - 8

ER -